Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
, , oraz
07 kwi 2022
O artykule
Kategoria artykułu: Research Article
Data publikacji: 07 kwi 2022
Zakres stron: 185 - 197
Otrzymano: 26 wrz 2021
Przyjęty: 28 sty 2022
DOI: https://doi.org/10.2478/raon-2022-0012
Słowa kluczowe
© 2022 Jiwon Choi, Jiyoung Park, Ilyoung Cho, Yhunyhong Sheen, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Choi, Jiwon
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Park, Jiyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Cho, Ilyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
Sheen, Yhunyhong
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea